Exosomal circRNA: emerging insights into cancer progression and clinical application potential
F Zhang, J Jiang, H Qian, Y Yan, W Xu - Journal of Hematology & …, 2023 - Springer
Exosomal circRNA serves a novel genetic information molecule, facilitating communication
between tumor cells and microenvironmental cells, such as immune cells, fibroblasts, and …
between tumor cells and microenvironmental cells, such as immune cells, fibroblasts, and …
Exosomal circular RNAs: a chief culprit in cancer chemotherapy resistance
Chemotherapy is one of the primary treatments for malignant tumors. However, the acquired
drug resistance hinders clinical efficacy and leads to treatment failure in most patients …
drug resistance hinders clinical efficacy and leads to treatment failure in most patients …
Modulating glycolysis to improve cancer therapy
Cancer cells undergo metabolic reprogramming and switch to a 'glycolysis-
dominant'metabolic profile to promote their survival and meet their requirements for energy …
dominant'metabolic profile to promote their survival and meet their requirements for energy …
Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment
J Li, L Zhu, HF Kwok - Drug Resistance Updates, 2023 - Elsevier
Lung cancer continues to be a malignant tumor with high mortality. Two obstacles interfere
with curative therapy of lung cancer:(i) poor diagnosis at the early stages, as symptoms are …
with curative therapy of lung cancer:(i) poor diagnosis at the early stages, as symptoms are …
Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy
C Xiao, H Tian, Y Zheng, Z Yang, S Li, T Fan… - Frontiers in Cell and …, 2022 - frontiersin.org
Cancer cells and immune cells all undergo remarkably metabolic reprogramming during the
oncogenesis and tumor immunogenic killing processes. The increased dependency on …
oncogenesis and tumor immunogenic killing processes. The increased dependency on …
The dual role of citrate in cancer
Citrate is a key metabolite of the Krebs cycle that can also be exported in the cytosol, where
it performs several functions. In normal cells, citrate sustains protein acetylation, lipid …
it performs several functions. In normal cells, citrate sustains protein acetylation, lipid …
Flubendazole enhances the inhibitory effect of paclitaxel via HIF1α/PI3K/AKT signaling pathways in breast cancer
Y Zhou, M Liao, Z Li, J Ye, L Wu, Y Mou, L Fu… - International Journal of …, 2023 - mdpi.com
Paclitaxel, a natural anticancer drug, is widely recognized and extensively utilized in the
treatment of breast cancer (BC). However, it may lead to certain side effects or drug …
treatment of breast cancer (BC). However, it may lead to certain side effects or drug …
The Ubiquitin–Proteasome System in Tumor Metabolism
J Wang, Y Xiang, M Fan, S Fang, Q Hua - Cancers, 2023 - mdpi.com
Simple Summary The reprogramming of tumor cell metabolism is an important char acteristic
of cancer, which provides the energy and biomacromolecules in tumor development …
of cancer, which provides the energy and biomacromolecules in tumor development …
COPS3 inhibition promotes cell proliferation blockage and anoikis via regulating PFKFB3 in osteosarcoma cancer cells
F Zhang, Q Li, Y Zhang, N Li, M Rao, S Li, Z Ai… - European Journal of …, 2023 - Elsevier
As a key component of the COP9 signalosome complex, which participates in a variety of
physiological processes, COPS3 is intimately related to multiple cancers. It promotes cell …
physiological processes, COPS3 is intimately related to multiple cancers. It promotes cell …
Oncogenic zinc finger protein ZNF687 accelerates lung adenocarcinoma cell proliferation and tumor progression by activating the PI3K/AKT signaling pathway
M Li, Z Liu, Z Hou, X Wang, H Shi, Y Li, X Xiao… - Thoracic …, 2023 - Wiley Online Library
Background Zinc finger protein 687 (ZNF687) has previously been discovered as a potential
oncogene in individuals with giant cell tumors of the bone, acute myeloid leukemia, and …
oncogene in individuals with giant cell tumors of the bone, acute myeloid leukemia, and …